Tigtig, Joseph B.

HRN: 23-58-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2025
CEFTAZIDIME 1GM (VIAL)
09/02/2025
09/08/2025
IV
1gm
Q8
HAP
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines